FIELD: medicine, dermatovenerology.
SUBSTANCE: the method deals with detecting the content of soluble form of HLA antigen I class in blood serum and at its increased level being above 2000 U/ml it is possible to establish the severe psoriasis flow, and at values being below 2000 U/ml - light flow.
EFFECT: higher accuracy of evaluation.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EVALUATION OF FUNCTIONAL STATE OF IMMUNOCOMPETENT CELLS IN PATIENTS WITH THERMAL TRAUMA | 2001 |
|
RU2200956C1 |
| METHOD OF ASSESSING THE SEVERITY OF PSORIASIS | 2022 |
|
RU2801467C1 |
| METHOD FOR EVALUATING THE CHARACTER OF DISEASE FLOW IN PATIENTS WITH DEGENERATIVE-DYSTROPHIC PATHOLOGY OF HIP JOINT | 2006 |
|
RU2315320C1 |
| METHOD FOR EVALUATING SEVERITY DEGREE OF PSORIASIS FLOW | 2000 |
|
RU2187116C2 |
| ENZYME IMMUNOASSAY METHOD FOR DETERMINATION OF SOLUBLE FORM OF ANTIGENS HLA-DR IN HUMAN BLOOD SERUM | 2002 |
|
RU2237249C2 |
| METHOD OF PSORIASIS TREATMENT | 2008 |
|
RU2391122C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH IMMUNODEFICIENCY STATE | 1999 |
|
RU2157234C1 |
| METHOD FOR TREATMENT OF HEAVY FORMS OF PSORIASIS | 2016 |
|
RU2620552C1 |
| METHOD FOR PROGNOSTICATING PROGRESS OF PSORIATIC ARTHRITIS | 1991 |
|
RU2032379C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING INHIBITORY FORM OF HAEMOPHILIA A | 2011 |
|
RU2469322C1 |
